Circulating Tumour DNA and Extracellular Vesicle-Associated DNA as…
Extracellular vesicle DNA offers a practical alternative to current blood tests for detecting cancer mutations, potentially expanding screening options.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Platelets: the next-generation ovarian cancer biomarker?
Platelets may carry early warning signs of ovarian cancer in blood, opening a path to catch the disease before symptoms appear.
Early cancer detection or preventionEvidence Rising, Integration Lagging
Blood-based cancer markers show promise for predicting liver transplant outcomes, but standardizing tests and speeding results could unlock their clinical potential.
Promising but preliminarySpatial and single-cell characterization of human glioblastoma tumor…
Mapping glioblastoma's internal structure reveals how tumor cells hide from the immune system, suggesting new targets for combination treatments.
Near-term implementable findingComparative assessment of diagnostic agreement between artificial…
AI-assisted eye screening matches specialist accuracy, potentially extending diabetic retinopathy detection to primary care and catching vision threats earlier.